Glycosaminoglycans are native components of the extracellular matrix that drive cell
behavior and control the microenvironment surrounding cells, making them promising …

Acute myocardial infarction (MI) occurs when blood flow to the myocardium is restricted,
leading to cardiac damage and massive loss of viable cardiomyocytes. Timely restoration of …

Cardiac fibrosis plays an indispensable role in cardiac tissue homeostasis and repair after
myocardial infarction (MI). The cardiac fibroblast-to-myofibroblast differentiation and …

Heart and kidney failure often co-exist and confer high morbidity and mortality. The complex
bi-directional nature of heart and kidney dysfunction is referred to as cardiorenal syndrome …

Excessive inflammation and impaired healing of cardiac tissue following a myocardial
infarction (MI) can drive the development of heart failure. Cardiac repair begins immediately …

Cardiovascular diseases (CVD) including acute myocardial infarction (AMI) rank first in
worldwide mortality and according to the World Health Organization (WHO), they will stay at …

We review some of the important discoveries and advances made in basic and translational
cardiac research in 2020. For example, in the field of myocardial infarction (MI), new aspects …

A feature of severe COVID-19 is the onset of an acute and intense systemic inflammatory
response referred to as the “cytokine storm”. The cytokine storm is characterized by high …

In the realm of modern medicine, tissue engineering and regeneration stands as a beacon
of hope, offering the promise of restoring form and function to damaged or diseased organs …

The popularity of Glycosaminoglycans (GAGs) in drug delivery systems has grown as their
innate ability to sequester and release charged molecules makes them adept in the …